Immunotherapy for Gastric Cancer: Time for a Personalized Approach?-Reference-Cited by-同舟云学术

Immunotherapy for Gastric Cancer: Time for a Personalized Approach?

Published:2018-05-29 Issue:6 Volume:19 Page:1602
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Dolcetti Riccardo,De Re Valli,Canzonieri Vincenzo^ORCID

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/6/1602/pdf

Reference130 articles.

1. Treatment options in patients with metastatic gastric cancer: Current status and future perspectives

2. TNM Classification of Malignant Tumors;Brierley,2017

3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

4. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

5. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Chemoimmunotherapy versus Chemotherapy for Gastric Cancer: A Meta-Analysis of Survival Outcomes;Current Medicinal Chemistry;2024-06

2. ScRNA-seq of gastric cancer tissues reveals differences in the immune microenvironment of primary tumors and metastases;Oncogene;2024-03-30

3. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study;International Journal of Surgery;2024-02-05

4. Immunoneoadjuvant therapy with immune checkpoint inhibitors of gastric cancer: an emerging exemplification;Investigational New Drugs;2023-11-16

5. Immunotherapy for advanced gastric cancer;World Journal of Methodology;2023-06-20